Sean Laaman
Stock Analyst at Morgan Stanley
(4.77)
Main Sectors:
9 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EXEL Exelixis | Maintains: Overweight | 46 50 | 40.09 | 24.72% | 2 | Sep 17, 2025 | |
IRON Disc Medicine | Maintains: Overweight | 85 90 | 67.78 | 32.78% | 2 | Aug 18, 2025 | |
AXSM Axsome Therapeutics | Assumes: Overweight | 190 | 120.3 | 57.94% | 1 | Jul 3, 2025 | |
CERT Certara | Assumes: Equal-Weight | 16 | 13.07 | 22.42% | 1 | Jul 3, 2025 | |
ONC BeOne Medicines | Maintains: Overweight | 313 330 | 343.87 | -4.03% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Underweight | 3 2 | 3.32 | -54.82% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 67 | 68.98 | -2.87% | 1 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 300 | n/a | n/a | 1 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 169 | 278.64 | -39.35% | 1 | Oct 27, 2023 |